Compassionate Use of Stanate (TM) [Stannsoporfin]

NO_LONGER_AVAILABLE

Conditions studied: Neonatal Jaundice, Hyperbilirubinemia

In brief

The purpose of this protocol is to make Stanate (TM) \[stannsoporfin, tin-mesoporphyrin\] available to infants who meet the following criteria: 1. the infant has a very high level of bilirubin without an adequate clinical response to phototherapy; 2. the infant requires an exchange transfusion; and 3. the family refuses to allow the administration of blood products, particularly on religious grounds, such as within the Jehovah's Witness community.

Key facts

Study ID

NCT00076960

Run by

InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company

Last updated by the study team

2019-10-15

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

Where it is running

• William Beaumont Hospital — Royal Oak, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.